Why can't individuals taking finasteride (dutasteride) donate plasma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Finasteride Use and Plasma Donation Restrictions

Individuals taking finasteride (or dutasteride) should not donate plasma due to the risk of teratogenic effects on female recipients of childbearing age, as these medications can persist in plasma and potentially harm a developing fetus. 1, 2

Why Finasteride is Restricted in Plasma Donation

Finasteride, a 5-alpha-reductase inhibitor used to treat male pattern baldness and benign prostatic hyperplasia, has specific properties that make it problematic for plasma donation:

  1. Teratogenic potential: Finasteride can cause abnormalities in male fetal development if pregnant women are exposed to it 2

  2. Persistence in plasma: Despite its relatively short half-life of 4.7-7.1 hours 3, finasteride can remain detectable in plasma beyond the expected elimination period

  3. Documented presence in donor plasma: Research has found measurable levels of finasteride in donor plasma specimens, with some exceeding recommended deferral periods 2

Scientific Evidence Supporting the Restriction

A key study analyzed stored blood specimens from donors who had taken teratogenic drugs and whose blood was transfused to women of childbearing age. The researchers found:

  • 7 specimens contained detectable finasteride
  • 1 specimen contained finasteride beyond the recommended drug deferral period 2

This evidence supports the concern that finasteride can persist in plasma and potentially be transferred to recipients.

Plasma Donation vs. Whole Blood Donation

It's important to understand the distinction:

  • Plasma donation: Specifically restricted for finasteride users due to the high concentration of the drug in plasma
  • Whole blood donation: May have different guidelines depending on the blood collection agency, as red blood cell components typically contain less than 50ml of plasma 1

Deferral Period Guidelines

For medications with teratogenic potential like finasteride:

  • A deferral period is required for all blood products
  • The standard approach for teratogenic drugs is to wait until the drug is completely eliminated from the body 1
  • For finasteride specifically, the deferral period is based on its pharmacokinetic properties

Alternative Options for Individuals on Finasteride

If you're taking finasteride and wish to help others through donation:

  1. Consider whole blood donation: Check with your local blood center as policies may differ for whole blood versus plasma donation

  2. Temporary discontinuation: If you wish to donate plasma, consult with your healthcare provider about temporarily stopping finasteride, considering the appropriate deferral period

  3. Other ways to contribute: Consider volunteering at blood drives or encouraging others to donate if you cannot donate yourself

Conclusion

The restriction on plasma donation while taking finasteride is a necessary safety measure to protect potential recipients, particularly pregnant women or women of childbearing age who might receive plasma products. This policy aligns with the fundamental principle of "do no harm" in medical practice and ensures the safety of blood products.

References

Research

Blood Donors on Medication - an Approach to Minimize Drug Burden for Recipients of Blood Products and to Limit Deferral of Donors.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.